Submitted by Anonymous (not verified) on 22 August 2023 - 11:21
Opinion/decision on a Paediatric investigation plan (PIP): Iscalimab, decision type: , therapeutic area: , PIP number: P/0222/2021
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Iscalimab, decision type: , therapeutic area: , PIP number: P/0222/2021